COVID-19 related prescribing guidance
Please see the COVID-19 Prescribing related information in the Formulary pages.
Ibuprofen and COVID-19
The Commission of Human Medicines (CHM) has been asked to review the safety of ibuprofen in patients with COVID-19. The Commission on Human Medicines’ Expert Working Group on coronavirus (COVID-19) has concluded that there is currently insufficient evidence to establish a link between use of ibuprofen, or other non-steroidal anti-inflammatory drugs (NSAIDs), and contracting or worsening of COVID-19 (1)
See link to full CMO letter below: